The melanoma models used in our study were derived from both primary and metastatic sites (including skin, lymph node, and brain) of both nodular and superficial spreading melanomas and almost generally harbored mutations in either BRAF or NRAS genes. Here, BRAF is linked to superficial spreading melanoma.